ZAIN KSA. Promising turnaround story OVERWEIGHT UPSIDE +16.3%

Similar documents
UNCERTAINTY SURROUNDS THE SECTOR

KSA Cement Sector. Domestic clinker sales aiding numbers. Cement Monthly. Oct-08. Aug-08. Sep-08. Dec-08. Jan-09. Nov-08. Feb-09

Almarai Steady performance

Saudi Arabia Cement Sector

Market Pulse. Inter. FFBL: Weak pricing power; Sell. Pakistan Fertilizer

Saudi Arabian Telecom Sector Q key takeaways

Zain KSA bogged down by high debt

Zain KSA restructuring ensures fresh start

Yamama Saudi Cement Company. Results Update 4 th Quarter 2011 MARCH Research Division Company Reports

The Company for Cooperative Insurance Insurance TAWUNIYA AB 8010.SE

Saudi Steel Pipes Co

Saudi Arabian Mining Co (Maaden AB Equity) Continuing steady performance

Bupa Arabia for Cooperative Insurance Co. Insurance BUPA ARABIA 8210.SE

Zain KSA still risky to invest

Advanced Petrochemicals Co Upgrade to OW. Raise TP to SAR61/share

Qassim Cement Company. Results Update 4 th Quarter 2011 MARCH Research Division Company Reports

Petro Rabigh Shutdown marred Q2 results

SABIC Overall strong performance

Fawaz Abdulaziz al Hokair & Co. Results Update 1st Quarter 2012/13 SEPTEMBER Research Division Company Reports

Yansab Better than expected results

Mobily high growth phase continues

National Industrialization Company (Tasnee) Flash Note. Quarterly results. Research Division Company Reports OCTOBER 2012

Strategy report All Industries All Sectors Saudi Arabia 13 March 2017 January 18, 2010

Al Hammadi and Care merger: First Look

Saudi Banks Sector Banks Finance Saudi Arabia 19 November 2017 January 18, 2010

Ma aden Equity infusion will strengthen balance sheet

FLASH NOTE Welspun India 31 Jan 17

Etihad Etisalat Company (EEC)

Market Pulse. Inter. Expect profits to grow substantially in 2QCY18. Pakistan Fertilizer

Etihad Etisalat Company (MOBILY) Flash Note. Quarterly results. Research Division Company Reports OCTOBER 2012

SACC Stronger growth expected

SAFARICOM LTD EARNINGS UPDATE MAY 2016

Market Pulse. Inter. ICI: Earnings growth intact despite drag from Life Sciences segment. Pakistan Chemicals

Turkcell EARNINGS REVIEW 4Q17. Digital transformation on track BUY

Sipchem Petrochemicals Industrial SIPCHEM AB: Saudi Arabia 07 August 2014

Overweight. VIVA Kuwait. Reiterate Overweight raising TP by 25% on lower capex guidance. 26 February 2015 Kuwait Telecoms

LARGE CAP & 1,970 BSE

SAFCO Q3: Margin beat as Urea price increases

STRATEGY. SAUDI BUDGET: ENHANCING EFFICIENCY AND DEVELOPMENT as

Saudi Basic Industries Corp After an upbeat Q3, expect good performance in Q4; Raise TP to SAR103/sh.

Saudi Ceramic Expansion plan key growth driver

Simmtech (222800) Focus on 2H earnings WHAT S THE STORY?

Fila Korea (081660) Widespread growth potential

Q4 EARNINGS REPORT Welspun India 25 Apr 17

Figure 1 Q results summary. Net profit 5,235 3, % 50% 5,879. Source: Company data, Al Rajhi Capital

Saudi Arabia BUY. Result Update. Saudi International Petrochemical Company (SIPCHEM) CMP: SR18.2 (as on May 03, 2009) Highlights

Saudi Arabian economy

Figure 1 SAFCO Q1 results Q Q Q (SAR mn) Operating profit % 375.6% 347. Operating margin 47% 8% 30% 40%

Saudi Real Estate Co (Akaria)

Saudi Company for Hardware (SACO) CMP: SAR 72, Target Price: SAR 62

GCC Telecom. GCC Telecom Sector Quarterly - 2Q12. Global Research Sector-Telecommunication 14 August 2012

2008A 2009E 2010E 2011E CAGR

Saudi Banks Sector Banks Finance Saudi Arabia 19 June 2017 January 18, 2010

Silicon Works (108320)

Coway ( KS) Good start to China water-purifier market entry. Korea Research KRW121,000 KRW103,000. Event. Impact. Action and recommendation

Mahindra and Mahindra Maintain Outperformer. (Rs mn) Mar 14 Mar 15 YoY (%) Dec 14 QoQ (%) FY14 FY15P YoY (%) FY16E YoY (%) FY17E YoY (%)

Saudi Insurance Sector- Quarterly

Saudi Arabian Economy

Silicon Works (108320)

LG Innotek (011070) Company Note. Concerns unjustified, 3Q14 results to beat consensus. BUY (Maintain)

Bank Al-Bilad. Summary. Investment Note May Underweight. Recommendation

Saudi Arabia HOLD. Result Update. SAMBA Financial Group Capital markets affect growth... CMP: SR73.3 (as on Jul 26, 2008)

National Industrialization Co. Diversified Operations Industrial NIC AB: Saudi Arabia 25 May 2014

YG Entertainment (122870)

Etihad Etisalat Co. (Mobily)

KWG. Seeking balance between scale and profitability. March 27, 2018 Equity Research. Stock code: 1813.HK Rating: HOLD Price target (HK$) 12.

Saudi Ground Services 3Q preview and Rating upgrade

CR Lands. Winner of next 5 years, BUY. March 21, 2018 Equity Research. Stock code: 1109.HK Rating: BUY Price target (HK$) 34.74

Symphony Ltd. RESULT UPDATE 31st October 2017

Symphony. Q3FY18 Result Update Strong performance; valuations expensive. Sector: Consumer Durable CMP: ` 1,970. Recommendation: HOLD

Tata Consultancy Services

Bayer Cropscience (BYRCS IN)

Kalpataru Power. Rating: Target price: EPS: Rating CMP. Target BUY. Rs Rs.256

Cement Dispatches for June 2018

SAFCO N: Weak Q2; Stock bottoming out Buy on further correction in H2

Nomu Parallel market Goes live with seven companies

KDDL (KDDL IN) In expansion mode

Colgate Palmolive (CLGT IN) Volume growth revival is the biggest positive

ITC Ltd. RESULT UPDATE 27th October, 2017

Fineotex Chemical Ltd

NIIT Technologies (NITEC IN) Strong performance across the board; maintain BUY

ContextVision. Neutral stance maintained after 3Q. 3Q14 Results analysis November 5 th 2014 Share price: NOK Target: NOK 24.

City of London Investment Group*

Century Plyboards. Result Update UNDER REVIEW. Ply revenue surprise, so does low interest cost AMBIT INSIGHTS

MCX Ltd. Rating: Target price: EPS: Tepid volume growth continues. Target. Rating CMP. Rs. 1,080 SELL. Rs. 1,176

Daewoo E&C ( KS) WHAT S THE STORY?

TCL Communication (2618 HK) Painful transition period. Buy (Maintain) Target Price HK$2.33 Up/downside +28.5% Current price HK$1.

Yanbu National Petrochemical Co (YANSAB)

Key estimate revision. Year CY14 87,383 11,148 6, CY15E 1,20,126 17,838 9,

BHEL (BHEL IN) Margins continue to disappoint

BUY. Suprajit Engineering (SEL) Automobiles

Infosys (INFO IN) Strong performance; small miss on margins maintain BUY

LG International (001120) Poor 3Q expected to be just a blip WHAT S THE STORY? SUMMARY OF 3Q RESULTS

Market Pulse. Inter. Regulatory changes weigh on auto sales. Pakistan Autos

Yamama Cement Company

Marico Kaya BUY RESULTS REVIEW 4QFY15 29 APR 2015

Siemens. Railways and T&D driving inflows. Source: Company Data; PL Research

FY20E FY21E FY20E FY21E

TAV Airports EARNINGS REVIEW 4Q17. Bottom-line below consensus BUY TRY22.90

Havells India. Q3FY17 Result Update Positive surprise; Maintain Buy. Sector: Consumer Durable CMP: ` 376. Recommendation: BUY.

Transcription:

TELECOM OVERWEIGHT UPSIDE +16.3 CURRENT PRICE SAR9.8 TARGET PRICE SAR11.4 RATING CHANGE Promising turnaround story We upgrade Zain to overweight with a TP of SAR11.4. We believe Zain s turnaround story is materializing, driven by 1) reduction of royalty fees, 2) royalty fees reversal and 3) tower sale. This will be further supported by Zain s inclusion in EM indices. We expect Zain to report a net income of SAR592mn in 2019f growing by 78.1 yoy. We expect a CAGR growth in sales of 3.4 between 2018-2022f, with a CAGR 1.2 growth in net income during the same period. The stock is trading at 2019f PE and EV/EBITDA of 9.0x and 3.8x, lower than the peer group average of 15.4x and 6.1x respectively. New services to support top-line growth: We expect Zain s revenues to grow 4.2 yoy in 2019 to SAR7.8bn. This compares to a growth of 3.1 in 2018 and 5.5 in 2017. We believe the growth will be driven by 1) growth in enterprise segment supported by government projects, 2) change in the client mix toward post-paid customers which represent 40 of the total customer base, 3) growth in FTTH, and 4) introducing new services. According to management, Zain expects to benefit from Dawiyat (FTTH infrastructure partner) to reach 180,000 homes. The company is also introducing new products such as cloud services, e-pay services and specialized new packages for Hajj and Umrah visitors. These factors are expected to offset the decline in mobile users in Saudi. Based on CITC Q3 18 data, mobile subscribers declined 3.5 yoy to 42.5mn, with a penetration rate of 131. Tower sale is key to reducing debt levels: Zain s BoD approved the sale and leaseback of its 8,100 towers to IHS for a total value of SAR2.43bn. The lease period is 15 years with an option to extend it for an additional 5 years. The offer also includes building 1,500 towers over the next 6 years. The average price/tower is US$80,000 which is lower than the last 4-year average of US$121,000. Proceeds from the transaction will be used to reduce debt levels, which currently stand at SAR10.2bn. We have not incorporated this transaction in our models as Zain awaits regulatory approvals and details about the leasing terms are not yet available. Although the debt level is expected to decline after the transaction is completed, the impact in the P&L is expected to be limited as the decline in financing charges will be offset by higher lease back expenses for the towers. Summary Financials SRmn 2018 2019f 2020f 2021f 2022f CAGR () Revenues 7,531 7,844 8,094 8,353 8,595 3.4 Gross Income 5,425 5,827 6,012 5,710 5,877 2.0 Gross margin () 72.0 74.3 74.3 68.4 68.4 Operating Income 1,219 1,507 1,460 1,000 993 (5.0) Operating margin () 16.2 19.2 18.0 12.0 11.6 Net income 332 592 649 301 349 1.2 Net margin () 4.4 7.5 8.0 3.6 4.1 EPS (SAR) 0.57 1.01 1.11 0.52 0.60 1.2 Source: Company, NCBC Research estimates STOCK DETAILS M52-week range H/L (SAR) 10/6 Market cap ($mn) 1,429 Shares outstanding (mn) 584 Listed on exchanges TADAWUL Price perform () 1m 3m 12m Absolute 4.7 47.7 40.3 Rel. to market 5.4 39.1 24.1 Avg daily turnover (mn) SAR US$ 3m 58.4 15.6 12m 32.1 8.6 Reuters code Bloomberg code VALUATION MULTIPLES 7030.SE ZAINKSA AB www.sa.zain.com 18 19f 20f PE (x) 16.1 9.0 8.3 PB (x) 1.3 1.2 1.0 EV/EBITDA (x) 4.7 3.8 3.5 Div Yield () 0.0 0.0 0.0 SHARE PRICE PERFORMANCE Source: Tadawul RELATIVE PERFORMANCE 160 140 120 100 80 60 15 12 9 6 3 0 - Mar-18 Sep-18 Mar-19 Source: Tadawul Volume (000)-RHS 30,000 25,000 20,000 15,000 10,000 5,000 Zain 40 Mar-18 Sep-18 Mar-19 Zain TASI Iyad Ghulam +966 12 690 7811 i.ghulam@alahlicapital.com Please refer to the last page for important disclaimer www.alahlicapital.com

An overview of royalty fee revision: Saudi telecom operators (STC, Mobily and Zain) signed agreements with the Ministry of Finance (MoF), the Ministry of Communication and Information Technology (MCIT) and CITC to settle the outstanding dispute related to royalty fees charged during 2009 to 2017 in addition to the amounts paid in 9M 18. The agreements aim to support the telecommunications sector and to stimulate investment in infrastructure, in-line with the National Transition Program (NTP) and Vision 2030. According to the agreements, royalties will be unified at a rate of 10 of net revenues, compared to 15 for voice, 8 for data and 10 for landline revenues. In return, companies will invest in their networks over the next 3 years. However, the details were not disclosed. Royalty fee revision expected to be a game changer: The impact of change in royalty fee will vary across companies, with Zain being the main beneficiary with an estimated cost reduction of SAR293mn/annually and a provision reversal of SAR1.7bn over 3 years. Actually, Zain reversed SAR300mn in 2018 with the outstanding amount of SAR1.4bn to be revised in 2019-2020, subject to meeting certain undisclosed requirements set in the agreement within 3 years. We believe this is a game changer for Zain, expanding its gross margins to 74.3 in 2019-2020 from 65.6 in 2017, based on a conservative reversal estimate of SAR1.3bn. The ability of the company to meet the requirements will further support margins in 2019-2020. Inclusion to EM indices to drive the stock: The Saudi market has been added to the MSCI and FTSE indices, with the first tranche for FTSE and MSCI expected in March 2019 and June 2019, respectively. Zain is expected to be added only to FTSE index with an expected weight of 0.4 and an inflow of SAR90mn. Although the estimated flow is limited, we expect the stock to be positively impacted supported mainly by 1) the attractive turnaround story and 2) the fact that the other two players in the sector (STC and Mobily) are included in both FTSE and MSCI indices with strong inflows. 5G to be launched in 2019f: Zain, along with other Saudi telecom operators are expected to launch 5G services in 2019f. We believe the launch of the service and expanding the coverage is part of the agreement with government authorities. However, we believe a gradual ramp-up of the service. We expect Zain s capex/sales ratio to be 20, lower than adjusted capex of 10 in 2018. Net income to grow 78.1 yoy in 2019f to SAR592mn: The change in royalty fees and the related reversals, along with top-line growth and lower debt levels are expected to support Zain s earnings. We expect Zain to report net income of SAR592mn in 2019f growing by 78.1 yoy. In 2020, net income is estimated to grow by 9.6. However, net income is expected to decline to SAR301mn in 2021 as the reversal period is concluded. Zain s ability to further control its costs will be the main growth driver going forward. 2

Financials Exhibit 1: Changes to estimates In SR mn, unless otherwise stated Old 2019f New 2019f Chg Gr Old 2020f New 2020f Chg Gr Revenue 7,316 7,844 7.2 4.2 7,525 8,094 7.6 3.2 Gross Profit 4,968 5,827 17.3 7.4 5,129 6,012 17.2 3.2 EBITDA 2,612 3,336 27.7 10.9 2,759 3,428 24.2 2.8 EBIT 841 1,507 79.1 23.6 877 1,460 66.4 (3.1) Net Profit (73) 592 NM 78.1 10 649 NM 9.6 Price target SAR 6.9 11.4 65.8. Exhibit 2: Income Statement In SR million, unless otherwise stated Revenues 7,531 7,844 8,094 8,353 8,595 8,827 change 3.1 4.2 3.2 3.2 2.9 2.7 Cost of services (2,106) (2,017) (2,081) (2,643) (2,718) (2,787) Gross profit 5,425 5,827 6,012 5,710 5,877 6,041 Gross margin () 72.0 74.3 74.3 68.4 68.4 68.4 Operating expenses (2,415) (2,491) (2,584) (2,596) (2,653) (2,726) EBITDA 3,009 3,336 3,428 3,114 3,224 3,315 EBITDA margin () 40.0 42.5 42.4 37.3 37.5 37.6 Dep. & Amortization (1,790) (1,828) (1,968) (2,114) (2,231) (2,329) EBIT 1,219 1,507 1,460 1,000 993 986 EBIT margin () 16.2 19.2 18.0 12.0 11.6 11.2 Financing costs (931) (960) (865) (752) (690) (592) Other inc./expenses, net 44 44 54 53 45 34 Pre-tax profit 332 592 649 301 349 428 Tax (Zakat) 0 0 0 0 0 0 Net income 332 592 649 301 349 428 change 2,780.3 78.1 9.6 (53.6) 15.8 22.8 Net margin () 4.4 7.5 8.0 3.6 4.1 4.9 EPS (SAR) 0.57 1.01 1.11 0.52 0.60 0.73 Exhibit 3: Balance Sheet In SR million, unless otherwise stated Cash & cash equivalents 1,417 1,735 1,716 1,445 1,105 1,171 Other current assets 2,528 2,172 2,225 2,551 2,608 2,660 Total current assets 3,945 3,907 3,941 3,997 3,713 3,830 Net fixed assets 6,123 6,542 6,883 7,146 7,361 7,548 Other assets - license fees 14,505 13,988 13,471 12,954 12,437 11,920 Other assets other licenses 119 176 247 336 448 588 Total non-current assets 22,379 22,226 22,011 21,735 21,432 21,131 Total assets 26,323 26,134 25,953 25,731 25,145 24,961 Current portion of long term borrowing 2,527 800 800 596 745 656 Other current liabilities 4,825 4,516 4,496 5,313 5,251 5,391 Total current liabilities 7,352 5,316 5,296 5,909 5,996 6,046 Long-term borrowings 7,668 8,406 7,606 6,479 5,465 4,809 Due to related party 5,457 5,943 6,584 7,111 7,111 7,111 Employee end of service benefits 93 82 72 64 56 49 Total non-current liabilities 14,959 16,213 15,403 14,268 13,246 12,583 Total liabilities 22,311 21,530 20,700 20,177 19,242 18,630 Share capital 5,837 5,837 5,837 5,837 5,837 5,837 Reserves & surplus (1,803) (1,212) (563) (262) 87 515 Shareholders' funds 4,012 4,604 5,253 5,554 5,903 6,331 Total equity & liabilities 26,323 26,134 25,953 25,731 25,145 24,961 3

Exhibit 4: Cash Flow Statement In SR million, unless otherwise stated Cash flow from op. (a) 1,836 3,942 3,399 3,650 3,142 3,430 Cash flow from inv.(b) (1,520) (1,676) (1,753) (1,838) (1,928) (2,027) NOPLAT 1,219 1,507 1,460 1,000 993 986 WC 300 (242) (73) 491 (119) 88 CAPEX (743) (1,569) (1,619) (1,671) (1,719) (1,765) Depreciation 1,790 1,828 1,968 2,114 2,231 2,329 Free cash flow 2,566 1,525 1,737 1,934 1,386 1,637 Cash flow from fin.(c) (15) (1,948) (1,665) (2,083) (1,555) (1,337) Net chg. in cash (a+b+c) 302 318 (18) (271) (341) 66 Cash at start of the year 1,116 1,417 1,735 1,716 1,445 1,105 Cash at end of the year 1,417 1,735 1,716 1,445 1,105 1,171 Exhibit 5: Key Ratios Per share, unless otherwise stated EPS 0.6 1.0 1.1 0.5 0.6 0.7 FCF per share 2.6 3.0 3.3 2.8 2.8 2.1 Div per share 0.0 0.0 0.0 0.0 0.0 0.0 Book value per share 6.9 7.9 9.0 9.5 10.1 10.8 Valuation ratios (x) P/E 16.1 9.0 8.3 17.8 15.4 12.5 P/FCF 3.5 3.1 2.8 3.3 3.3 4.4 P/BV 1.3 1.2 1.0 1.0 0.9 0.8 EV/sales 1.9 1.6 1.5 1.3 1.2 1.1 EV/EBITDA 4.7 3.8 3.5 3.5 3.2 2.9 Div yield () 0.0 0.0 0.0 0.0 0.0 0.0 Profitability ratios () Gross margins 72.0 74.3 74.3 68.4 68.4 68.4 Operating margin 16.2 19.2 18.0 12.0 11.6 11.2 EBITDA margins 40.0 42.5 42.4 37.3 37.5 37.6 Net profit margins 4.4 7.5 8.0 3.6 4.1 4.9 ROE 8.8 13.7 13.2 5.6 6.1 7.0 ROA 1.3 2.3 2.5 1.2 1.4 1.7 Liquidity ratios Current ratio 0.5 0.7 0.7 0.7 0.6 0.6 Quick Ratio 0.5 0.7 0.7 0.6 0.6 0.6 Operating ratios (days) Inventory 39 39 39 39 39 39 Receivables outstanding 53 50 49 48 47 46 Trade and other payables outstanding 711 681 651 621 591 590 Operating cycle 92 89 88 87 86 85 Cash cycle (619) (593) (564) (535) (506) (506) Leverage Ratios Debt/Equity 2.5 2.0 1.6 1.3 1.1 0.9 Net Debt/ EBITDA 2.9 2.2 2.0 1.8 1.6 1.3 Interest Coverage ratio 1.3 1.6 1.7 1.3 1.4 1.7 4

Kindly send all mailing list requests to research@alahlicapital.com NCBC Research website Brokerage website Corporate website http://research.alahlicapital.com www.alahlitadawul.com www.alahlicapital.com NCBC Investment Ratings OVERWEIGHT: NEUTRAL: UNDERWEIGHT: PRICE TARGET: Other Definitions Target price represents an increase in the share price in excess of 15 in the next 12 months Target price represents a change in the share price between -10 and +15 in the next 12 months Target price represents a fall in share price exceeding 10 in the next 12 months Analysts set share price targets for individual companies based on a 12 month horizon. These share price targets are subject to a range of company specific and market risks. Target prices are based on a methodology chosen by the analyst as the best predictor of the share price over the 12 month horizon NR: Not Rated. The investment rating has been suspended temporarily. Such suspension is in compliance with applicable regulations and/or in circumstances when NCB Capital is acting in an advisory capacity in a merger or strategic transaction involving the company and in certain other situations CS: Coverage Suspended. NCBC has suspended coverage of this company NC: Not covered. NCBC does not cover this company Important information The authors of this report hereby certify that the views expressed in this document accurately reflect their personal views regarding the securities and companies that are the subject of this document. The authors also certify that neither they nor their respective spouses or dependants (if relevant) hold a beneficial interest in the securities that are the subject of this document. Funds managed by NCB Capital and its subsidiaries for third parties may own the securities that are the subject of this document. NCB Capital or its subsidiaries may own securities in one or more of the aforementioned companies, or funds or in funds managed by third parties The authors of this document may own securities in funds open to the public that invest in the securities mentioned in this document as part of a diversified portfolio over which they have no discretion. The investment banking division of NCB Capital may be in the process of soliciting or executing fee earning mandates for companies that are either the subject of this document or are mentioned in this document. This document is issued to the person to whom NCB Capital has issued it. This document is intended for general information purposes only, and may not be reproduced or redistributed to any other person. This document is not intended as an offer or solicitation with respect to the purchase or sale of any security. This document is not intended to take into account any investment suitability needs of the recipient. In particular, this document is not customized to the specific investment objectives, financial situation, risk appetite or other needs of any person who may receive this document. NCB Capital strongly advises every potential investor to seek professional legal, accounting, tax and financial guidance when determining whether an investment in a security is appropriate to his or her needs. Any investment recommendations contained in this document take into account both risk and expected return. Information and opinions contained in this document have been compiled or arrived at by the author are from sources believed to be reliable, but NCB Capital has not independently verified the contents of this document and such information may be condensed or incomplete. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on the fairness, accuracy, completeness or correctness of the information and opinions contained in this document. To the maximum extent permitted by applicable law and regulation, NCB Capital shall not be liable for any loss that may arise from the use of this document or its contents or otherwise arising in connection therewith. Any financial projections, fair value estimates and statements regarding future prospects contained in this document may not be realized. All opinions and estimates included in this document constitute the author s judgment as of the date of production of this document, and are subject to change without notice. Past performance of any investment is not indicative of future results. The value of securities, the income from them, the prices and currencies of securities, can go down as well as up. An investor may get back less than he or she originally invested. Additionally, fees may apply on investments in securities. Changes in currency rates may have an adverse effect on the value, price or income of a security. No part of this document may be reproduced without the written permission of NCB Capital. Neither this document nor any copy hereof may be distributed in any jurisdiction outside the Kingdom of Saudi Arabia where its distribution may be restricted by law. Persons who receive this document should make themselves aware, of and adhere to, any such restrictions. By accepting this document, the recipient agrees to be bound by the foregoing limitations. NCB Capital is authorised by the Capital Market Authority of the Kingdom of Saudi Arabia to carry out dealing, as principal and agent, and underwriting, managing, arranging, advising and custody, with respect to securities under licence number 37-06046. The registered office of NCB Capital is at King Saud Road, NCB Regional Building P.O. Box 22216, 11495 Riyadh, Kingdom of Saudi Arabia. About Exotix Capital Exotix Capital is a registered trade mark of Exotix Partners LLP. Exotix Partners LLP and its subsidiaries ("Exotix Capital") provide specialist investment banking services to trading professionals in the wholesale markets. Exotix Capital draws together liquidity and matches buyers and sellers so that deals can be executed by its customers. Exotix Capital may at any time, hold a trading position in the securities and financial instruments discussed in this report. Exotix Capital has procedures in place to identify and manage any potential conflicts of interests that arise in connection with its research. A copy of Exotix Capital s conflict of interest policy is available at www.exotix.com/regulatory-information. This research is prepared by NCB Capital, with headquarters in Riyadh, Saudi Arabia. NCB Capital is authorized to engage in securities activities according to its domestic legislation. This research is not a product of Exotix USA, Inc, a U.S. registered broker-dealer. NCB Capital has sole control over the contents of this research report. Exotix USA, Inc does not exercise any control over the contents of, or the views expressed in, research reports prepared by NCB Capital. Distribution This report is not intended for distribution to the public and may not be reproduced, redistributed or published, in whole or in part, for any purpose without the written permission of Exotix Capital and NCB Capital. Exotix Capital and NCB Capital shall accept no liability whatsoever for the actions of third parties in this respect. This report is for distribution only under such circumstances as may be permitted by applicable law. 5

This report may not be used to create any financial instruments or products or any indices. Neither Exotix Capital and NCB Capital, nor their members, directors, representatives, or employees accept any liability for any direct or consequential loss or damage arising out of the use of all or any part of the information herein. United States of America: NCB Capital is not registered as a broker-dealer in the United States and, therefore, is not subject to U.S. rules regarding the preparation of research reports and the independence of research analysts. This research report is provided for distribution to major U.S. institutional investors and other U.S. institutional investors in reliance on the exemption from registration provided by Rule 15a-6 of the U.S. Securities Exchange Act of 1934, as amended (the Exchange Act ). Any U.S. recipient of this research report wishing to effect any transaction to buy or sell securities or related financial instruments based on the information provided in this research report should do so only through Exotix USA, Inc, located at Floor 36, 444 Madison Avenue, Floor 36, New York, NY 10022. A representative of Exotix USA, Inc. is contactable on +1 (212) 551 3480. Exotix USA, Inc accepts responsibility for the contents of this research report, subject to the terms set out below, to the extent that it is delivered to a U.S. person other than a major U.S. institutional investor. None of the materials provided in this report may be used, reproduced, or transmitted, in any form or by any means, electronic or mechanical, including recording or the use of any information storage and retrieval system, without written permission from Exotix Capital and NCB Capital. NCB Capital is the employer of the research analyst(s) responsible for the content of this report and research analysts preparing this report are resident outside the U.S. and are not associated persons of any U.S. regulated broker-dealer. The analyst whose name appears in this research report is not registered or qualified as a research analyst with the Financial Industry Regulatory Authority ( FINRA ) and may not be an associated person of Exotix USA, Inc and, therefore, may not be subject to applicable restrictions under FINRA Rules on communications with a subject company, public appearances and trading securities held by a research analyst account. Exotix USA, Inc. or its affiliates has not managed or co-managed a public offering of securities for the subject company in the past 12 months, has not received compensation for investment banking services from the subject company in the past 12 months, and does not expect to receive or intend to seek compensation for investment banking services from the subject company in the next three months. Exotix USA, Inc. has never owned any class of equity securities of the subject company. There are no other actual, or potential, material conflicts of interest of Exotix USA, Inc. at the time of the publication of this report. As of the publication of this report, Exotix USA, Inc. does not make a market in the subject securities. United Kingdom: Distributed by Exotix Partners LLP only to Eligible Counterparties or Professional Clients (as defined in the FCA Handbook). The information herein does not apply to, and should not be relied upon by, Retail Clients (as defined in the FCA Handbook); neither the FCA s protection rules nor compensation scheme may be applied. Other distribution: The distribution of this report in other jurisdictions may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restriction. Disclaimers Exotix Capital and/or its members, directors or employees may have interests, or long or short positions, and may at any time make purchases or sales as a principal or agent of the securities referred to herein. Exotix Capital may rely on information barriers, such as Chinese Walls to control the flow of information within the areas, units, divisions, groups of Exotix Capital. Investing in any non-u.s. securities or related financial instruments (including ADRs) discussed in this report may present certain risks. The securities of non-u.s. issuers may not be registered with, or be subject to the regulations of, the U.S. Securities and Exchange Commission. Information on such non- U.S. securities or related financial instruments may be limited. Foreign companies may not be subject to audit and reporting standards and regulatory requirements comparable to those in effect within the United States. The value of any investment or income from any securities or related financial instruments discussed in this report denominated in a currency other than U.S. dollars is subject to exchange rate fluctuations that may have a positive or adverse effect on the value of or income from such securities or related financial instruments. Frontier and Emerging Market laws and regulations governing investments in securities markets may not be sufficiently developed or may be subject to inconsistent or arbitrary interpretation or application. Frontier and Emerging Market securities are often not issued in physical form and registration of ownership may not be subject to a centralised system. Registration of ownership of certain types of securities may not be subject to standardised procedures and may even be effected on an ad hoc basis. The value of investments in Frontier and Emerging Market securities may also be affected by fluctuations in available currency rates and exchange control regulations. Not all of these or other risks associated with the relevant company, market or instrument which are the subject matter of the report are necessarily considered. 6